BioSpace News Archive

Press Releases

Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024

October 31, 2024
·
1 min read
Press Releases

ChromaDex Corporation Reports Third Quarter 2024 Financial Results

October 31, 2024
·
15 min read
Press Releases

Verastem Oncology Completes Rolling NDA Submission to the FDA for Avutometinib Plus Defactinib as a Treatment for Recurrent KRAS Mutant Low-Grade Serous Ovarian Cancer

October 31, 2024
·
13 min read
Press Releases

Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

October 31, 2024
·
5 min read
Press Releases

ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer

October 31, 2024
·
8 min read
Press Releases

PharmaDrug’s Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases

October 31, 2024
·
7 min read
Press Releases

Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024

October 31, 2024
·
2 min read
Press Releases

Bristol Myers Squibb Presents New Long-term Data from the EMERGENT Program Evaluating COBENFY™ (xanomeline and trospium chloride) in Adults with Schizophrenia at Psych Congress 2024

October 31, 2024
·
14 min read
Press Releases

Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

October 31, 2024
·
17 min read
Press Releases

Adaptimmune to Report Q3 2024 Financial and Business Updates on Wednesday, November 13, 2024

October 31, 2024
·
2 min read